I Indivumed is a biotech company focusing on precision oncology. For almost 25 years, we have been driven by a single, overarching vision: a world in which precision therapy offers a cure for every cancer patient.
Specialized in early drug discovery, our R&D approach is based on the belief that we need to fundamentally understand the disease to gain novel insights and develop effective therapeutics. To do so, we start with carefully collected and curated patient samples, resulting in a comprehensive and proprietary database. By employing advanced biomathematical and bioinformatic methods on this excellent data, we discover therapeutically novel targets. From our high-quality tissue, we generate patient-derived 2D and 3D cellular models allowing us to perform target validation and therapeutic development in an environment that is as close to the patient as possible.
Drive, dedication, and our shared purpose make us who we are.
Driven by our pioneering spirit and our shared purpose, we explore the complexity of cancer with curiosity and determination. Thriving on innovation, we value unique perspectives and visionary scientific approaches to grow together_._ Whether as a scientist, as a data analyst, or in a corporate function – everyone contributes to our common goal.
If you thrive on discovery, come join our team and make your impact!
We are looking for an exceptional Scientist to lead our efforts in the identification and characterization of novel therapeutic antibodies. You will be the subject matter expert for flow cytometry, responsible for standardizing, executing and analyzing high-throughput screening of hybridomas targeting critical cancer surface proteins.

Indivumed is a biotech company focused on precision oncology. With our unique approach to collecting tissue and data of unmatched quality and variety, we have unlocked a deep understanding of the molecular reality of cancer. This way, we are able to discover novel therapeutic targets that would otherwise be undetectable. Through in-house efforts we can progress small and large molecules toward IND and beyond. With more than 20 years of innovation, we remain true to our vision: a world where precision oncology offers a cure for every cancer patient. To learn more about our mission, visit www.indivumed.com.
Imprint: https://www.indivumed.com/imprint
Privacy Policy Social Media: https://www.indivumed.com/data-protection-policy-social-media/